Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPID | Q08752 | 1/20 | 0.53 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | METAP2 | P50579 | 1/20 | 0.48 |
| ▸ | METAP1 | P53582 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.41 |
| ▸ | FNTB | P49356 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL112746 | 1.00 | PPID (0.53) | PPIDDRD1METAP2METAP1L3MBTL1 | |
| SCHEMBL752327 | 0.94 | DRD1 (0.50) | PPIDDRD1METAP2METAP1L3MBTL1 | |
| SCHEMBL28016251 | 0.94 | DRD1 (0.50) | PPIDDRD1METAP2METAP1L3MBTL1 | |
| SCHEMBL113048 | 0.87 | L3MBTL1 (0.44) | PPIDDRD1L3MBTL1GAAALDH1A1 | |
| SCHEMBL113049 | 0.87 | L3MBTL1 (0.44) | PPIDDRD1L3MBTL1GAAALDH1A1 | |
| SCHEMBL111170 | 0.86 | ALDH1A1 (0.56) | L3MBTL1KMT2AGAAALDH1A1USP2 | |
| SCHEMBL11205882 | 0.86 | ALDH1A1 (0.56) | L3MBTL1KMT2AGAAALDH1A1USP2 | |
| SCHEMBL111169 | 0.86 | ALDH1A1 (0.56) | L3MBTL1KMT2AGAAALDH1A1USP2 | |
| SCHEMBL111322 | 0.84 | L3MBTL1 (0.42) | PPIDDRD1L3MBTL1GAAALDH1A1 | |
| SCHEMBL111323 | 0.84 | L3MBTL1 (0.42) | PPIDDRD1L3MBTL1GAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102802605-A | Stable lipid formulations of apoptosis promoters | ABBOTT LAB | 2012-11-28 | — | — | CN | claimed |
| EP-2424499-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | Abbott Laboratories (US) | 2012-03-07 | — | — | EP | claimed |
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBVIE INC. | 2010-11-04 | — | — | US | claimed |
| WO-2010127193-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | claimed |
| EP-0022361-B1 | DEHYDRATED AMINO ACID FOOD ADDITIVES, THEIR PREPARATION AND USE IN FOODSTUFFS | THE PROCTER & GAMBLE COMPANY (US) | 1983-07-27 | — | — | EP | claimed |
| US-4379177-A | Stable dehydrated cocrystalline amino acid food additives | THE PROCTER & GAMBLE COMPANY (US) | 1983-04-05 | — | — | US | claimed |
| EP-0022361-A1 | Dehydrated amino acid food additives, their preparation and use in foodstuffs | THE PROCTER & GAMBLE COMPANY (US) | 1981-01-14 | — | — | EP | claimed |
| US-3952115-A | Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters | THE PROCTER & GAMBLE COMPANY (US) | 1976-04-20 | — | — | US | claimed |
| US-6372788-B1 | — | — | None | — | — | US | disclosed |
| WO-2021038426-A1 | SUBSTITUTED 1,3-PHENYL HETEROARYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | NOVARTIS AG (CH) | 2021-03-04 | — | — | WO | disclosed |
| CN-105820138-A | ABT-263 crystalline forms and solvates for use in treating BCL-2 protein related diseases | ABBVIE 公司 | 2016-08-03 | — | — | CN | disclosed |
| CN-102655858-B | ABT-263 capsule | ABBVIE (US) | 2015-11-25 | — | — | CN | disclosed |
| CN-102802605-B | Stable lipid formulations of apoptosis promoters | ABBVIE (US) | 2015-08-12 | — | — | CN | disclosed |
| EP-1756047-B1 | PROCESS FOR PREPARING AMINO ACIDS USING THE AMIDOCARBONYLATION REACTION (1) | EVONIK DEGUSSA GMBH (DE) | 2015-07-01 | — | — | EP | disclosed |
| EP-1128738-A1 | A METHOD FOR SUPPLYING BIOAVAILABLE METHIONINE TO A COW | AVENTIS ANIMAL NUTRITION S.A. (FR) | 2001-09-05 | — | — | EP | disclosed |
| US-20010008904-A1 | Method for supplying bioavailable methionine to a cow | RHONE-POULENC ANIMAL NUTRITION | 2001-07-19 | — | — | US | disclosed |
| US-6221909-B1 | ADMINISTERING TO THE COW THE ISOPROPYL ESTER OF THE HYDROXY ANALOGUE OF METHIONINE. | RHôNE-POULENC ANIMAL NUTRITION (FR) | 2001-04-24 | — | — | US | disclosed |
| WO-2000028835-A1 | A METHOD FOR SUPPLYING BIOAVAILABLE METHIONINE TO A COW | AVENTIS ANIMAL NUTRITION S.A. (FR) | 2000-05-25 | — | — | WO | disclosed |
| EP-0025141-B1 | PROCESS FOR THE PRODUCTION OF 1-AMINO-CYCLOPROPANE-CARBOXYLIC ACID AND ITS DERIVATIVES | BAYER AG (DE) | 1982-05-12 | — | — | EP | disclosed |
| US-3952115-A | Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters | THE PROCTER & GAMBLE COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | BCL2, BAX, BCOR | PPID 2804/4885DRD1 3579/4885METAP2 4253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.